US Broker Ratings

BioNTech SE (BNTX): Investor Outlook on Biotech Leader with a 17.41% Potential Upside

BioNTech SE (NASDAQ: BNTX) has positioned itself as a significant player in the biotechnology sector, offering promising potential for investors seeking exposure to innovative healthcare solutions...

TG Therapeutics, Inc. (TGTX): Analyst Consensus Highlights Promising Upside in Biotech Sector

Investors seeking opportunities in the dynamic biotechnology sector might want to keep a close eye on TG Therapeutics, Inc. (NASDAQ: TGTX), a company that has recently..

Quest Diagnostics (DGX) Stock Analysis: A Healthcare Leader with a 12% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization..

Medpace Holdings, Inc. (MEDP) Investor Outlook: Navigating the Growth Path Amidst Market Dynamics

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a notable market capitalization..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Market Challenges with Innovation and Potential Upside

Moderna, Inc. (NASDAQ: MRNA) is a prominent player in the biotechnology sector, widely recognized for its revolutionary mRNA technology that has significantly impacted the healthcare landscape...

Incyte Corporation (INCY) Stock Analysis: Navigating Growth in the Biotech Sector with a 7.42% Upside Potential

Incyte Corporation (NASDAQ: INCY) stands at the forefront of the biotechnology industry, offering a diverse portfolio of therapeutics that cater to a wide array of medical..

Haleon plc (HLN) Stock Analysis: 21% Potential Upside Beckons Investors

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves with its robust portfolio of consumer healthcare products. This UK-based company, with a..

Thermo Fisher Scientific Inc. (TMO) Stock Analysis: Exploring a 15% Upside Potential Amid Robust Revenue Growth

Thermo Fisher Scientific Inc. (NYSE: TMO), a titan in the diagnostics and research industry, continues to capture the attention of investors with its substantial market cap..

DaVita Inc. (DVA) Stock Analysis: Unveiling a 10.56% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector, is capturing investor attention with a notable potential upside of 10.56%. As a cornerstone in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with 13% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to innovative biopharmaceuticals. With a robust..

GE HealthCare Technologies Inc. (GEHC): Investor Outlook on 13.34% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s consistent growth. With a market capitalization of..

Insmed Incorporated (INSM) Stock Analysis: Biotech’s 11.31% Potential Upside Captures Investor Attention

Insmed Incorporated (NASDAQ: INSM), a formidable player in the biotechnology sector, has been making waves with its innovative therapies for serious and rare diseases. With a..

Revolution Medicines, Inc. (RVMD) Investor Outlook: A 90% Upside Potential in the Precision Oncology Market

Revolution Medicines, Inc. (NASDAQ: RVMD) stands out in the biotechnology sector with a compelling narrative focused on precision oncology, particularly in the realm of RAS-addicted cancers...

Repligen Corporation (RGEN) Stock Analysis: Exploring a 47.59% Potential Upside in the Booming Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, is capturing investor attention with its robust growth prospects and significant potential upside. Headquartered in..

BioMarin Pharmaceutical Inc. (BMRN): Analyst Ratings Suggest a Robust 63.12% Upside – What Investors Need to Know

BioMarin Pharmaceutical Inc. (BMRN) is making waves in the biotechnology sector, particularly with its focus on developing therapies for life-threatening rare diseases. With a market capitalization..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech with Over 100% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing opportunity for investors in the healthcare sector, specifically within biotechnology. With a market capitalization of $7.24 billion, this..

Universal Health Services, Inc. (UHS) Stock Analysis: A 44% Upside Awaits Investors

Universal Health Services, Inc. (UHS), a stalwart in the healthcare sector, operates a robust network of acute care hospitals and behavioral health facilities across the United..

Glaukos Corporation (GKOS) Stock Analysis: Exploring the 29.70% Potential Upside in the Healthcare Sector

Glaukos Corporation (NYSE: GKOS) has captured the attention of investors with its innovative approach in the healthcare sector, particularly in the medical devices industry. The company’s..

AstraZeneca PLC (AZN): Investor Outlook Highlights Promising 18.20% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a global powerhouse in the biopharmaceutical sector, continues to capture investor attention with its robust market presence and a promising potential upside..

Qiagen N.V. (QGEN) Stock Analysis: Navigating Growth in Diagnostics with a $11.22 Billion Market Cap

Qiagen N.V. (QGEN), headquartered in Venlo, the Netherlands, stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds